Continental Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Continental Advisors's PFE Position: Q3 2026 in Review
Continental Advisors reduced its Pfizer (PFE) stake by 1.1% in Q3 2026, selling an estimated $120K and leaving 410,938 shares worth $11.7M. The position accounts for 5.02% of the portfolio, ranked #3.
Continental Advisors first reported a position in PFE in Q2 2013 and has held it in 54 quarters since. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Continental Advisors held 410,938 shares of Pfizer worth $11.7M as of Q3 2026.
- Continental Advisors sold 4,500 Pfizer shares in Q3 2026, an estimated $120K.
- Pfizer made up 5.02% of Continental Advisors's portfolio in Q3 2026, its #3 holding.
- Continental Advisors first reported a position in Pfizer in Q2 2013 and has held it in 54 quarters since.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Continental Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.